The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy of naxitamab in patients with refractory/relapse (R/R) high-risk neuroblastoma (HR-NB) by bone/bone marrow (BM) evaluation, potential sites of residual disease.
 
Brian H. Kushner
No Relationships to Disclose
 
Daniel A. Morgenstern
Consulting or Advisory Role - Bayer; Boehringer Ingelheim; Clarity Pharmaceuticals; EUSA Pharma; Roche; Ymabs Therapeutics Inc
Speakers' Bureau - Ymabs Therapeutics Inc
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - EUSA Pharma
 
Karsten Nysom
Consulting or Advisory Role - Bayer; Y-mAbs Therapeutics
 
Melissa K. Bear
Employment - Lilly
Stock and Other Ownership Interests - Lilly
 
Karen Tornøe
Employment - Y-mAbs Therapeutics
Stock and Other Ownership Interests - Y-mAbs Therapeutics
 
Nedjad Losic
Employment - Y-mAbs Therapeutics
 
Jaume Mora
Consulting or Advisory Role - Y-mAbs Therapeutics